Lilly’s Eczema Drug Shows Durable Long-Term Response in Late-Stage Study
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
LILLYS-ECZEMA-DRUG-SHOWS-DURABLE-LONG-TERM-RESPONSE
